SoFi's Record Quarter Highlights Valuation Gap, But Key Risks Remain

What happened

SoFi reported record quarterly results and raised full-year revenue guidance, yet shares remain near 52-week lows, reflecting persistent market skepticism. The master report notes strong Q2 metrics: net revenue up 43% to $1.22B, GAAP net income up 61% to $156.6M, and member growth of 35% to 15.8M. However, the market focuses on the quality of growth: net interest income still dominates (64% of revenue), personal-loan credit metrics are stable but high (3.7% NCO ex-sale, 40bps 90-day delinquency), and Technology Platform revenue fell 23% YoY. The raised guidance ($4.75B-$4.85B revenue) was not accompanied by an increase in EBITDA guidance (~$1.6B), signaling lower margin conversion and reinforcing the 'growth without quality' concern. While the business fundamentals are solid and deposits provide a funding advantage, the stock's discount persists because investors need proof of a shift toward capital-light revenue before rerating.

Implication

The news does not change the 'POTENTIAL BUY' rating, as the key thesis checkpoints remain unresolved: personal-loan charge-offs need to stay below 3.7% through Q4, fee-based revenue must hold above 39% of total, and Technology Platform must stop declining. The raised revenue guidance without a corresponding EBITDA increase suggests margin compression, which could cap multiple expansion. Attractive entry remains near $16, with a trim above $21; current price of ~$17.30 is within range but not a screaming buy. Monitor Q3 earnings for credit trends and any LPB partner additions; if credit deteriorates, the bear case ($14) becomes more likely. Conversely, early signs of tech platform stabilization or stronger fee mix would increase conviction.

Thesis delta

No material change to the investment thesis. The news article reinforces the view that SoFi's operational performance is strong but the market remains focused on lending-heavy growth and credit risk, which aligns with our existing 'POTENTIAL BUY' rating. The raised guidance without EBITDA uplift slightly increases concern about margin conversion, but this is already incorporated in our base case.